Valeant Pharmaceuticals: What's the Stock Worth Now?
Valeant's intrinsic value has collapsed, but what's it worth today? Image source: PRI's Studio 360, republished under CC BY 2.0 .
SAP CEO: The political system is a lot like business
SAP CEO on politics and his business vision
NIAID Director: We could see local outbreaks of Zika virus in the U.S.
Global Zika virus outbreak fears
Cigna/Anthem Not Exiting Obamacare, Unlike UnitedHealth
Is Obamacare in a death spiral? Not so fast.
UnitedHealth to Exit Most ObamaCare Exchanges in 2017: CEO
UnitedHealth Group Inc Chief Executive Officer Steven Hemsley said on Tuesday that the company would largely exit the Obamacare exchange market in 2017, following through on a warning he had given late last year that costs appeared to be unsustainable.
UnitedHealth's ObamaCare Exit Adds Pricing Pressure on Rivals
UnitedHealth Group Inc's decision to exit most of its Obamacare health insurance exchanges next year means rivals will need to raise prices further to prop up an unprofitable business, healthcare analysts and policy experts said on Tuesday.
Why the U.S. Doctor Shortage is Getting Worse
The U.S. will face a physician shortage over the next decade; potentially as many as 90,000 doctors could be needed.
Judge Napolitano: Courts should respect businesses leaving Obamacare
UNH leaving Obamacare
Bye-Bye: UnitedHealth Exiting All But a Handful of Obamacare Exchanges in '17
UnitedHealth Group Inc Chief Executive Officer Steven Hemsley said on Tuesday that the company would largely exit the Obamacare exchange market in 2017, following through on a warning he had given late last year that costs appeared to be unsustainable.
Theranos Under Investigation by Several U.S. Regulators
Blood-testing firm Theranos Inc confirmed on Monday it is under investigation by federal prosecutors and the U.S. Securities and Exchange Commission.
UnitedHealth Raises 2016 Earnings Outlook
Health insurer UnitedHealth Group raised its expectations for 2016 profit, in part because of a more favorable tax rate that also helped it beat Wall Street expectations for the first quarter.
J&J Shares to Hit Record After Earnings
Johnson & Johnson, the maker of Band-Aids and Tylenol, reported higher-than-expected quarterly earnings on Tuesday and nudged up its 2016 sales and earnings forecasts.
Valeant Pharmaceuticals' Stock in 4 Charts
Image source: Pixabay , public domain For this Fool, the rise and fall of Valeant Pharmaceuticals International Inc (NYSE: VRX) is the most fascinating business story of 2015 -- and there are still a few chapters yet to be written.
Ben Carson: Assisted suicide is wrong
Assisted suicide debate
Concussion forces NFL player to retire at 23
NFL and concussions
CDC official on Zika virus: We are most concerned about pregnant women
Zika virus concerns
We tested out the world’s first 3D fitness tracker
3D fitness tracker
More Americans turning to short-term health policies to save money
Rise of short-term health policies
Feds Propose Banning Theranos Founder
Federal health regulators have proposed banning Theranos Inc. founder Elizabeth Holmes from the blood-testing business for at least two years after concluding that the company failed to fix what regulators have called major problems at its laboratory in California.

















